SUMMARY TERM SHEET. Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL )

Size: px
Start display at page:

Download "SUMMARY TERM SHEET. Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL )"

Transcription

1 SUMMARY TERM SHEET Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL ) 2. Date of resolution May 28, 2014 passed by the Board of Directors authorizing the Issue 3. Date of special July 24, 2014 (Annual General Meeting) resolution passed by the shareholders authorizing the Issue 4. Instrument Rated Listed Cumulative Compulsorily Redeemable Non- Convertible Preference Shares ( CRPS ) 5. Seniority Claims of the CRPS Holders shall rank senior to claims of any holder of equity shares of the Company and shall rank pari passu with all other preference shares issued by the Company. Claims of the CRPS Holder shall be subordinated to the both secured and unsecured creditors of the Company 6. Mode of Issue Private Placement 7. Listing BSE Limited CRPS shall be listed within 20 days from the Deemed Date of Allotment 8. Rating CARE AA+(RPS) by CARE. Instruments with this rating are considered to have high degree of safety regarding timely servicing of financial obligations. Such instruments carry very low credit risk. 9. Issue Size 4,00,00,000 CRPS aggregating to Rs. 400,00,00, Option to retain Up to 2,00,00,000 CRPS aggregating up to Rs. 200,00,00,000 oversubscription 11. Objects of the Issue The funds raised through this Issue shall be utilized to maintain adequate working capital as may be required for funding the operations of the Company and that of its subsidiaries. 12. Utilization of Issue proceeds 13. Interest on Application Money The Company shall utilize the proceeds of the Issue solely for meeting the Objects of the Issue as stated in the Information Memorandum The Company shall pay to the successful applicants, interest at the rate of 8.15% p.a. on the amount allotted, from and including the date of receipt of application money in the Designated Account till one day prior to Deemed Date of Allotment, subject to applicable tax laws.

2 14. Interest on Refund Amount (excluding the valid rejections) The Company shall pay to the successful applicants, interest at the rate of 8.15% p.a. on the refund amount, from and including the date of receipt of the money in the Designated Account till one day prior to Deemed Date of Allotment, subject to applicable tax laws. However, the Company shall not be liable to pay any interest on monies liable to be refunded in case of: a) Invalid Applications/ or Applications liable to be rejected; b) Applications which are withdrawn by the Applicant(s); c) Monies paid in excess of the amount of CRPS applied for in the Application Form. 15. Face Value Rs. 100 per CRPS 16. Premium/ Discount Nil on Issue 17. Issue Price Rs. 100 per CRPS 18. Tenor 5 years (60 months) from the Deemed Date of Allotment 19. Redemption Date* May 08, 2020 * Redemption Date may change based on the actual Deemed Date of Allotment. 20. Dividend Rate 8.15% p.a. 21. Dividend Payment Annual Frequency 22. Redemption Nil Premium/ Discount 23. Redemption Price Rs. 100 per CRPS 24. Redemption Amount Rs. 100 per CRPS plus any Dividend accrued but not paid from any previous Dividend Payment Date 25. Put / Call Option None 26. Put Option Date Not Applicable 27. Put Option Price Not Applicable 28. Put Notification Not Applicable Time 29. Call Option Date Not Applicable 30. Call Option Price Not Applicable 31. Call Notification Not Applicable Time 32. Minimum Application and in multiples thereafter Rs crore (1,00,000 CRPS) and in multiples of Rs. 25 lac (25,000 CRPS) thereafter

3 33. Dividend Payment Dates and Redemption Date Dividend Payment Dates and Redemption Date Revised Dividend Payment Date and Redemption Date Dividend for the period From and including Upto and including For the financial year No. of days Amount payable per CRPS (Rs.), 06-May-2015^ Sat, 26-Mar-2016 Mon, 28-Mar May Mar Sun, 26-Mar-2017 Mon, 27-Mar Apr Mar Mon, 26-Mar Apr Mar Tue, 26-Mar Apr Mar Thu, 26-Mar Apr Mar Wed, 06-May- 2020* Notes & Assumptions: - 01-Apr May ^ Adjustment of application money paid by the Investors on account of allotment of CRPS. * Inclusive of redemption amount of Rs. 100 per CRPS. a. Dividend amount has been 8.15% p.a. rounded off to four decimals per CRPS. The amount of Dividend payable may vary subject to the Accelerated Redemption Clause. b. In pursuance of clause on Business Day Convention, all days (other than Saturdays and Sundays) on which the banks are open for business in Mumbai, have been considered as Business Days. c. The first Dividend Payment Date is falling on 26-Mar-2016, which is a Saturday and therefore not a Business Day. Likewise the second Dividend Payment Date is falling on 26- Mar-2017, which is a Sunday and therefore not a Business Day.As per Business Day Convention, if any Dividend Payment Date falls on a day that is not a Business Day, payment shall be made on the immediately succeeding Business Day without any obligation for paying dividend for the intervening period. Therefore the first Dividend Payment shall be made on 28-Mar-2016 (immediately succeeding Business Day) and second Dividend Payment shall be made on 27-Mar-2017 (immediately succeeding Business Day), without any obligation for paying dividend for the intervening period. d. For the purpose of the above illustration, it has been assumed that only Saturdays and Sundays are non-business Days. The notified/ gazette/ other bank holidays cannot be ascertained as of now and therefore their impact has not been captured in the above illustration. e. If the Deemed Date of Allotment is preponed/ postponed, the Redemption Date shall also stand modified and the amount of Dividend payable on the first and the last Dividend Payment Date shall also undergo change. 34. Change in Tax In the event of any change in applicable tax laws on account of which

4 Laws Rights of CRPS Holders Mode of redemption Issuance Mode Trading Mode the Dividend received by the CRPS Holders becomes subject to any tax to the account of the CRPS Holders, the Company shall declare and pay such additional amounts as Dividend such that the total amount received by the CRPS Holders as Dividend ( Aggregate Dividend Rate ) in relation to the CRPS less the tax payable on account of the change in applicable law is equivalent to the Dividend Rate as set out above. However, in the event of such change in applicable tax laws, the Company reserves the right to exercise the Accelerated Redemption Clause wherein the redemption of CRPS may be preponed as described below. In pursuance of sub-section (2) of section 47 of the Companies Act, 2013, every member of a Company and holding any CRPS shall, in respect of such capital, have a right to vote only on resolutions placed before the Company which directly affect the rights attached to his CRPS and, any resolution for the winding up of the Company or for the repayment or reduction of its equity or preference share capital and his voting right on a poll shall be in proportion to his share in the paid-up preference share capital of the Company. Provided that the proportion of the voting rights of equity shareholders to the voting rights of the holders of CRPS shall be in the same proportion as the paid-up capital in respect of the equity shares bears to the paid-up capital in respect of the CRPS. However in case where the dividend in respect of CRPS has not been paid for a period of two years or more, such CRPS Holders shall have a right to vote on all the resolutions placed before the Company. The CRPS shall be redeemed out of profits of the Company which would otherwise be available for Dividend or out of the proceeds of a fresh issue of shares made for the purposes of such redemption. Demat only Demat only Background of the company: L&TFHL is promoted by L&T and was incorporated as L&T Capital Holdings Limited on May 01, 2008, under the Companies Act, 1956, to carry on the business of investment/finance and received the certificate of commencement of business on May 15, Subsequently, the company changed the name to L&T Finance Holdings Limited from September 01, 2010, and received fresh certificate of incorporation from the Registrar of Companies on September 06, Prior to March 31, 2009, L&TFH had minimal operations with passive investments. It acquired 100% stake in L&T Finance Limited (LTF) and L&T Infrastructure Finance Limited (L&T Infra) on March 31, The company came up with an Initial Public Offer (IPO) during FY12 (refers to the period April to March), consequent to which, the stake of L&T diluted to 82.64%. However, L&T continues to hold controlling stake in the company and the management of L&TFHL is mainly drawn from the senior management of L&T. Financial Background: L&TFHL reported a consolidated Profit After Tax (PAT) of Rs.597 crore on a total income of Rs.5,237 crore in FY14 as compared with a PAT of Rs.730 crore on a total income of Rs.3,995 crore in FY13. In Q1FY15, the company reported PAT of Rs.286 crore on total income of Rs.1,469 crore. Rating Rationale by CARE

5 The rating factors in the strategic importance of L&T Finance Holdings Ltd (L&TFHL) to the L&T group as the flagship holding company of its financial services business, brand value of L&T, experienced management, L&TFH s strong consolidated financial position, and strong resource-raising ability. The rating further factors in L&TFH s well-diversified business profile in the financial sector through its direct and indirect subsidiaries that have good presence and track record in segments like retail finance, corporate finance, infrastructure finance and asset management services as well as the profitability track record of its subsidiaries. Continued support from L&T, profitability and the asset quality of loan portfolio of its subsidiaries are the key rating sensitivities. Source: CARE Credit Rating

These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017.

These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017. Rules of Membership 1. Introduction These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017. The previously published

More information

PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public

PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public Incorporation of BVI Business Companies under the BVI Business Companies Act, 2004 1. Introduction The following is a brief summary of the main

More information

RULES OF CONDUCT OF INSIDERS RESPECTING

RULES OF CONDUCT OF INSIDERS RESPECTING T RULES OF CONDUCT OF INSIDERS RESPECTING RADING O F SECURITIES OF TFI International lnc. Amended and restated July 2015 Executive Summary As an insider of TFI International Inc. ( TFI International )

More information

PROSPECTUS. Offer of up to 300,000 Convertible Resettable Preference Shares to raise up to $30,000,000. Whitefield Limited ABN

PROSPECTUS. Offer of up to 300,000 Convertible Resettable Preference Shares to raise up to $30,000,000. Whitefield Limited ABN PROSPECTUS Offer of up to 300,000 Convertible Resettable Preference Shares to raise up to $30,000,000 Whitefield Limited ABN 50 000 012 895 Lead Manager Legal advisers IMPORTANT NOTICES About this Prospectus

More information

CITY OF VALLEJO HIDDENBROOKE IMPROVEMENT DISTRICT NO IMPROVEMENT LEVY ADMINISTRATION REPORT FISCAL YEAR

CITY OF VALLEJO HIDDENBROOKE IMPROVEMENT DISTRICT NO IMPROVEMENT LEVY ADMINISTRATION REPORT FISCAL YEAR CITY OF VALLEJO HIDDENBROOKE IMPROVEMENT DISTRICT NO. 1998-1 IMPROVEMENT LEVY ADMINISTRATION REPORT FISCAL YEAR 2010-11 December 17, 2010 Hiddenbrooke Improvement District No. 1998-1 Improvement Levy Administration

More information

Development Bank of Southern Africa Amendment Bill [B ]

Development Bank of Southern Africa Amendment Bill [B ] Development Bank of Southern Africa Amendment Bill [B 2-2014] Briefing of Standing Committee on Finance National Assembly 8 July 2014 Presenters: Mr Lefentse Radikeledi Director: Asset and Liability Management

More information

MINUTES OF THE ANNUAL SOLVAY S.A. SHAREHOLDERS MEETING On Tuesday, May 10, 2016 at 10:30 a.m.

MINUTES OF THE ANNUAL SOLVAY S.A. SHAREHOLDERS MEETING On Tuesday, May 10, 2016 at 10:30 a.m. MINUTES OF THE ANNUAL SOLVAY S.A. SHAREHOLDERS MEETING On Tuesday, May 10, 2016 at 10:30 a.m. The shareholders of the company Solvay S.A. with its corporate offices in Brussels, rue de Ransbeek, no. 310,

More information

Development Bank of Southern Africa Amendment Bill [B ]

Development Bank of Southern Africa Amendment Bill [B ] Development Bank of Southern Africa Amendment Bill [B 2-2014] Briefing of Select Committee on Finance National Council of Provinces 21 October 2014 Presenters : Mr Ben Mokheseng Deputy Director: Asset

More information

ESM Pricing Policy. Element of Pricing and Calculation of Interest Rate. 1. Base Rate

ESM Pricing Policy. Element of Pricing and Calculation of Interest Rate. 1. Base Rate ESM Pricing Policy Objective When granting stability support, the ESM shall aim to fully cover its financing and operating costs and shall include an appropriate margin (Art. 20 of the Treaty). The main

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q 10-Q 1 v402511_10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT 1934. For the

More information

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes 1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements

More information

ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update

ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update - All Three Development Compounds Progressing with Key Clinical Milestones Over the Next 12 Months - Geneva, Switzerland

More information

Summary of Results for the First Half of FY2015/3

Summary of Results for the First Half of FY2015/3 Summary of Results for the First Half of FY2015/3 November 10, 2014 Tokyu Corporation (9005) http://www.tokyu.co.jp/ Contents Ⅰ.Executive Summary 2 Ⅱ.Conditions in Each Business 5 Ⅲ.Details of Financial

More information

Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, András Tövisi Chairman of the Board of Directors

Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, András Tövisi Chairman of the Board of Directors Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, 2014 András Tövisi Chairman of the Board of Directors Philip Morris ČR a.s. Annual General Meeting of Shareholders 2014

More information

CENTRALE. Monetary. compared. domestic. million.

CENTRALE. Monetary. compared. domestic. million. CENTRALE BANK VAN ARUBAA Statistical News Release Second Quarter 2012 Date: November 7, 2012 Monetary and financial developments Money and credit In the second quarterr of 2012, the money supply decreased

More information

Organisational reporting of completion fees apply

Organisational reporting of completion fees apply Self reporting of completion free service Proof of completion of all courses is provided to all learners in the form of a printable and emailable Certificate of Completion. Learners can use these certificates

More information

Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update TIME-2b Clinical Trial of AKB-9778 in Patients with Diabetic Retinopathy Remains on Track Conference Call

More information

THIRD QUARTER REPORT 2011 (UNAUDITED)

THIRD QUARTER REPORT 2011 (UNAUDITED) THIRD QUARTER REPORT 2011 (UNAUDITED) Kronprinsesse Märthas pl. 1, Vika, 0166 Oslo, Norway. Tel: + 47 23 01 09 60, www.bionorpharma.com Page 1 THIRD QUARTER REPORT 2011 HIGHLIGHTS On the 25th August Bionor

More information

Operational Efficiency:

Operational Efficiency: Operational Efficiency: metrics that matter Copyright Altus Ltd 214. All rights reserved. Kevin Okell Consultancy Director 15/5/214 From distribution chain to value chain Ad-valorem pricing driven from

More information

FY2007 Consolidated Financial Overview

FY2007 Consolidated Financial Overview FY2007 Consolidated Financial Overview CHUGAI PHARMACEUTICAL CO., LTD. Executive Vice President and CFO Ryuzo Kodama January 30/31, 2008 Forward-Looking Statements This presentation may include forward-looking

More information

MEMORANDUM ASSOCIATION

MEMORANDUM ASSOCIATION MEMORANDUM OF ASSOCIATION MEMORANDUM OF ASSOCIATION THE COMPANIES ACT, 1985 COMPANY LIMITED BY GUARANTEE AND NOT HAVING A SHARE CAPITAL MEMORANDUM OF ASSOCIATION OF GERDA BOYESEN INTERNATIONAL INSTITUTE

More information

All CRPS will have a maturity date of 18 months from the date of issuance of the first tranche of CRPS ( Maturity Date ).

All CRPS will have a maturity date of 18 months from the date of issuance of the first tranche of CRPS ( Maturity Date ). HIBISCUS PETROLEUM BERHAD ( Hibiscus Petroleum or Company ) Proposed Private Placement of CRPS Proposed Increase in Authorised Share Capital Proposed Amendments to the Memorandum and Articles of Association

More information

General Terms and Conditions

General Terms and Conditions General Terms and Conditions Revision history (November 2007) Date issued Replaced pages Effective date 11/07 ii, iii, 2, 4 11/07 11/06 all pages 11/06 01/06 all pages 01/06 02/05 ii, iii, 4, 7 8 02/05

More information

MANAGEMENT. MGMT 0021 THE MANAGEMENT PROCESS 3 cr. MGMT 0022 FINANCIAL ACCOUNTING 3 cr. MGMT 0023 MANAGERIAL ACCOUNTING 3 cr.

MANAGEMENT. MGMT 0021 THE MANAGEMENT PROCESS 3 cr. MGMT 0022 FINANCIAL ACCOUNTING 3 cr. MGMT 0023 MANAGERIAL ACCOUNTING 3 cr. MANAGEMENT MGMT 0021 THE MANAGEMENT PROCESS 3 cr. An introduction designed to emphasize the basic principles, practices, and terminology essential to the understanding of contemporary business and its

More information

Sumitomo Dainippon Pharma to Acquire Tolero Pharmaceuticals, Inc. (US Biotechnology Company)

Sumitomo Dainippon Pharma to Acquire Tolero Pharmaceuticals, Inc. (US Biotechnology Company) December 21, 2016 Sumitomo Dainippon Pharma Co., Ltd. Sumitomo Dainippon Pharma to Acquire Tolero Pharmaceuticals, Inc. (US Biotechnology Company) Sumitomo Dainippon Pharma Co., Ltd. (Head office: Osaka,

More information

GENERAL TERMS AND CONDITIONS WCO PUBLICATIONS

GENERAL TERMS AND CONDITIONS WCO PUBLICATIONS Version 1.0 GENERAL TERMS AND CONDITIONS WCO PUBLICATIONS These General Terms and Conditions govern all sales of Publications, on paper and/or in digital format whether directly at the Sales Counter or

More information

DRAFT FOR PUBLIC COMMENT Guidance Note for ESS9 Financial Intermediaries

DRAFT FOR PUBLIC COMMENT Guidance Note for ESS9 Financial Intermediaries The Guidance Notes provide guidance for the Borrower on the application of the Environmental and Social Standards (ESSs), which form part of the World Bank s 2016 Environmental and Social Framework. The

More information

Q Investor Kit JANUARY-MARCH 2014

Q Investor Kit JANUARY-MARCH 2014 Q1 2014 Investor Kit JANUARY-MARCH 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco

More information

BVI Limited Partnership Hedge Funds: Calling Japan

BVI Limited Partnership Hedge Funds: Calling Japan BERMUDA BRITISH VIRGIN ISLANDS CAYMAN ISLANDS CYPRUS DUBAI HONG KONG LONDON MAURITIUS MOSCOW SÃO PAULO SINGAPORE conyersdill.com June 2012 BVI Limited Partnership Hedge Funds: Calling Japan Structuring

More information

Family Application: Nanny / Mother s Helper

Family Application: Nanny / Mother s Helper 14509 Grand Avenue Omaha, NE 68116 Office: 402-218-1370 Fax: 888-202-7738 Family Application: Nanny / Mother s Helper Family Last Name Home Number Home Fax Mother s Name Email Address Home Address City

More information

ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update

ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update -Key First Quarter 2018 Clinical Milestones Achieved Patient randomization completed in Phase 2b EDELWEISS trial of OBE2109

More information

Interim report Second quarter 2017 and subsequent events (Unaudited)

Interim report Second quarter 2017 and subsequent events (Unaudited) SERODUS ASA Interim report Second quarter 2017 and subsequent events (Unaudited) August 2017 2017-08-15 Q2-2017 report ABOUT SERODUS Serodus is a private biotech company with a focus on diabetic comorbidities

More information

Growth of s 1 lac invested on inception date. SIP Performance: Scheme Name 1 Yr 2 Yr 3 Yr 4 Yr 5 Yr. CNX Midcap

Growth of s 1 lac invested on inception date. SIP Performance: Scheme Name 1 Yr 2 Yr 3 Yr 4 Yr 5 Yr. CNX Midcap BNP Paribas Midcap The investment objective of the is to seek to generate long-term capital appreciation by investing primarily in companies with high growth opportunities in the middle and small capitalization

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q 10-Q 1 v393825_10q.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

More information

For personal use only

For personal use only ASX RELEASE (23 rd March 2018) AGM PowerPoint Presentaion In accordance with the requirements of Listing Rule 3.1 we submit the attached material being distributed at the Company s Annual General Meeting

More information

Dainippon Pharmaceutical and Sumitomo Pharmaceuticals Finalize Merger Agreement

Dainippon Pharmaceutical and Sumitomo Pharmaceuticals Finalize Merger Agreement For immediate release April 28, 2005 Dainippon Pharmaceutical and Sumitomo Pharmaceuticals Finalize Merger Agreement Dainippon Pharmaceutical Co., Ltd. Sumitomo Pharmaceuticals Co., Ltd. Dainippon Pharmaceutical

More information

General Terms and Conditions

General Terms and Conditions General Terms and Conditions Revision history (July 2008) Date issued Replaced pages Effective date 07/08 all pages 07/08 11/07 ii, iii, 2, 4 11/07 11/06 all pages 11/06 01/06 all pages 01/06 02/05 ii,

More information

Telekom Austria Group Results for the 1st Quarter May 27, 2003

Telekom Austria Group Results for the 1st Quarter May 27, 2003 Telekom Austria Group Results for the 1st Quarter 2003 May 27, 2003 1 Cautionary Statement This presentation contains certain forward-looking statements. Actual results may differ materially from those

More information

Q Investor Kit January December 2014

Q Investor Kit January December 2014 Q4 2014 Investor Kit January December 2014 Highlights for Q4 Sales up for all product areas and operating profit from product areas up by 8% Scandinavian hoarding for snus prior to tax increase in January

More information

Terms & Conditions of Trade

Terms & Conditions of Trade Terms & Conditions of Trade T/A Koda Lighting 1. Definitions 1.1 Koda Lighting means ATF McCall Fox Family Trust T/A Koda Lighting, its successors and assigns or any person acting on behalf of and with

More information

NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results

NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results July 31, 2015 NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results -Management to Host Conference Call Today at 8:30 a.m. ET- AMES, Iowa, July 31,

More information

1Q2017 法人說明會 Jun. 9, 2017

1Q2017 法人說明會 Jun. 9, 2017 1Q2017 法人說明會 Jun. 9, 2017 FE group business Span over 10 major industries Own over 240 companies Established in 1937 9 public listed companies in Taiwan and HK Petrochemical & energy Polyester & synthetic

More information

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM November 28, 2017 DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM Dr. Jürgen Wunram Agenda Diebold Nixdorf AG History and shareholder structure Market trends, strategy and progress of integration Diebold Nixdorf

More information

Q Investor Kit JANUARY-JUNE 2013

Q Investor Kit JANUARY-JUNE 2013 Q2 2013 Investor Kit JANUARY-JUNE 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)

More information

Oncolytics Biotech Inc. Announces Third Quarter 2010 Results

Oncolytics Biotech Inc. Announces Third Quarter 2010 Results November 10, 2010 Oncolytics Biotech Announces Third Quarter 2010 Results CALGARY, Nov. 10 /PRNewswire-FirstCall/ - Oncolytics Biotech (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced

More information

ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update

ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update IMPLANT 4 trial of nolasiban in IVF starting in Q4 2018, European MAA filing expected late 2019 24-week data from Phase

More information

Investor Relations 1Q 2017

Investor Relations 1Q 2017 Investor Relations 1Q 2017 History Leading Authentic Sports Brand Inspired by the Style, Elegance and Passion of our Italian Heritage Founded by FILA brothers in Biella, Italy Established FILA Korea FILA

More information

Q Investor Kit JANUARY-MARCH 2013

Q Investor Kit JANUARY-MARCH 2013 Q1 2013 Investor Kit JANUARY-MARCH 2013 1 Swedish Match reporting segments Snus and snuff - Swedish snus (Scandinavia and US) - Moist snuff (US) - SMPM International Other tobacco products - Cigars (US)

More information

Q2 INVESTOR KIT JANUARY-JUNE 2011

Q2 INVESTOR KIT JANUARY-JUNE 2011 Q2 INVESTOR KIT JANUARY-JUNE 2011 Swedish Match reporting segments Reporting segments following the transaction with STG on October 1, 2010 Snus and snuff - Swedish snus in Scandinavia and US - US moist

More information

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical For immediate release November 25, 2004 Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical Sumitomo Chemical Co., Ltd. announced today that its subsidiary, Sumitomo

More information

Interim Report 1 January September 2017

Interim Report 1 January September 2017 2014-01-01 2014-12 Interim Report 1 January 2017 30 September 2017 Cantargia AB 556791-6019 Cantargia refers to Cantargia AB (publ), corporate ID number 556791-6019. Clinical trial initiated Highlights

More information

NHS: 2005 PCA(D)11 abcdefghijklm

NHS: 2005 PCA(D)11 abcdefghijklm NHS: 2005 PCA(D)11 abcdefghijklm = eé~äíü=aéé~êíãéåí= = aáêéåíçê~íé=çñ=mêáã~êó=`~êé=~åç=`çããìåáíó=`~êé= = mêáã~êó=`~êé=aáîáëáçå= = pí=^åçêéïdë=eçìëé= = oéöéåí=oç~ç= = bafk_rode= = ben=pad= Dear Colleague

More information

ThromboGenics Business Update H1 2018

ThromboGenics Business Update H1 2018 Press release 6 September 2018 Regulated Information ThromboGenics Business Update H1 2018 Positive Topline Results for Diabetic Eye Disease Portfolio Shareholder approval for company name change to Oxurion

More information

Argos Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results

Argos Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results March 27, 2014 Argos Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results - AGS-003 Phase 3 ADAPT Trial on Track to Complete Enrollment This Year - - AGS-004-Induced Immune Responses

More information

Q Investor Kit January December 2015

Q Investor Kit January December 2015 Q4 2015 Investor Kit January December 2015 Summary and Overview 2 Q4 and full year 2015: Headline numbers Sales for the full year increased by 9 percent and for the fourth quarter by 5 percent. In local

More information

Q Investor Kit JANUARY-JUNE 2014

Q Investor Kit JANUARY-JUNE 2014 Q2 2014 Investor Kit JANUARY-JUNE 2014 Swedish Match reporting segments Snus and moist snuff Snus (Scandinavia and US) Moist snuff (US) SMPM International Other tobacco products Cigars (US) Chewing tobacco

More information

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018 CPH Chemie + Papier Holding AG Investor Day Perlen, 13 th September 2018 Agenda 2.00 pm Welcome 2.05 pm Presentation Course of Business 2018 2.50 pm Break 3.00 pm Presentation Perlen Packaging 3.30 pm

More information

Name and address of the Borrower

Name and address of the Borrower 1 THE TERMS AND CONDITIONS OF SALE TO BE UPLOADED ON THE WEBSITE OF THE SECURED CREDITOR Property will be sold on AS IS WHERE IS, AS IS WHAT IS AND WHATEVER THERE IS Basis Name and address of the Borrower

More information

INVESTOR PRESENTATION

INVESTOR PRESENTATION INVESTOR PRESENTATION May 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities regulation.

More information

FORM8-K HILLENBRAND,INC.

FORM8-K HILLENBRAND,INC. UNITEDSTATES SECURITIESANDEXCHANGECOMMISSION Washington,D.C.20549 FORM8-K CURRENTREPORT PursuanttoSection13or15(d)oftheSecuritiesExchangeActof1934 Date of Report (Date of earliest event reported): December18,2015

More information

Company overview. Highlights for the 1 st quarter 2018 (January-March)

Company overview. Highlights for the 1 st quarter 2018 (January-March) Company overview Vaccibody is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies. The company is a leader in the rapidly developing field of

More information

Legal framework for the development of commodity based financing. Krassimir Kiriakov International WHR Expert

Legal framework for the development of commodity based financing. Krassimir Kiriakov International WHR Expert Legal framework for the development of commodity based financing Krassimir Kiriakov International WHR Expert Goal and Objectives of the WHR system Goal :To enable cooperation among the government, financial

More information

Investor Presentation

Investor Presentation Investor Presentation February 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities

More information

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014 1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include

More information

2017 Annual General Meeting

2017 Annual General Meeting Cedar Woods Presentation 1 Cedar Woods Properties Limited 2017 Annual General Meeting 9 November 2017 Cedar Woods Presentation 2 Agenda 1 Chairman s Address Mr William G Hames 2 Managing Director s Review

More information

AFFIN HOLDINGS BERHAD (Company No.: W) (Incorporated in Malaysia under the Companies Act, 2016) NOTICE TO SHAREHOLDERS IN RELATION TO THE

AFFIN HOLDINGS BERHAD (Company No.: W) (Incorporated in Malaysia under the Companies Act, 2016) NOTICE TO SHAREHOLDERS IN RELATION TO THE THIS NOTICE IS FOR YOUR INFORMATION ONLY. YOU ARE NOT REQUIRED TO TAKE ANY ACTION. Bursa Malaysia Securities Berhad ( Bursa Securities ) takes no responsibility for the contents of this Notice, makes no

More information

BANK HANDLOWY W WARSZAWIE S.A. 1Q 2009 consolidated financial results -1-

BANK HANDLOWY W WARSZAWIE S.A. 1Q 2009 consolidated financial results -1- BANK HANDLOWY W WARSZAWIE S.A. 1Q 29 consolidated financial results -1- Macroeconomic situation in 1Q 29 Deep drop in industrial output in January and February, albeit business confidence indicators suggest

More information

1Q 2015 Results A Positive Start to 2015

1Q 2015 Results A Positive Start to 2015 1Q 2015 Results Main Events Operating Results Order Backlog Financial Performance Update on Disposal 1Q 2015 Results A Positive Start to 2015 Rome - May 14, 2015 1Q 2015 Main Backlog Events 1Q 2015 Results

More information

THE GYMNASIUMS AND FITNESS CENTRES (REGULATION) BILL, 2016

THE GYMNASIUMS AND FITNESS CENTRES (REGULATION) BILL, 2016 1 AS INTRODUCED IN LOK SABHA Bill No. 78 of 2016 5 THE GYMNASIUMS AND FITNESS CENTRES (REGULATION) BILL, 2016 By SHRI A.T. NANA PATIL, M.P. A BILL to provide for regulation of gymnasiums and fitness centres

More information

5). Loving Nannies will fax or mail you the background check and your caregiver can officially start!

5). Loving Nannies will fax or mail you the background check and your caregiver can officially start! How Loving Nannies Works About Us-Loving Nannies has been placing nannies since 2000 and is an A+ accredited member of the Better Business Bureau. We have been featured in multiple publications such as

More information

YEAR END REPORT. September 2013 August Diamyd Medical AB (publ), Fiscal year 2013/2014

YEAR END REPORT. September 2013 August Diamyd Medical AB (publ), Fiscal year 2013/2014 YEAR END REPORT September 2013 August 2014 Diamyd Medical AB (publ), Fiscal year 2013/2014 Reporting period, June 1, 2014 August 31, 2014 Net sales amounted to MSEK 0.2 (0,1) Loss before tax amounted to

More information

Family Application: Nanny / Mother s Helper

Family Application: Nanny / Mother s Helper 132 Gold Bridge Crossing Canton, GA 30114 Office: 678-659-9296 Fax: 678-528-7494 Family Application: Nanny / Mother s Helper Family Last Name Home Number Home Fax Mother s Name Email Address Home Address

More information

APPENDIX 4C SEPTEMBER 2018 QUARTER

APPENDIX 4C SEPTEMBER 2018 QUARTER Date: 26 October 2018 Sydney, Australia ASX: NOX Noxopharm Limited ABN 50 608 966 123 Registered Office and Operational Office: Suite 3, Level 4 828 Pacific Highway Gordon NSW 2072 Australia ASX Limited

More information

AMERICAN BOARD OF ADOLESCENT PSYCHIATRY

AMERICAN BOARD OF ADOLESCENT PSYCHIATRY AMERICAN BOARD OF ADOLESCENT PSYCHIATRY SUPPORTED BY THE AMERICAN SOCIETY FOR ADOLESCENT PSYCHIATRY Candidate Guide & Certification Examination Application American Society For Adolescent Psychiatry P.O.

More information

PROACTIVE INVESTOR PRESENTATION

PROACTIVE INVESTOR PRESENTATION www.thcl.com.au ASX RELEASE (16 th May 2017) PROACTIVE INVESTOR PRESENTATION The Hydroponics Company Limited (ASX: THC) is pleased to advise that Dr Andrew Beehag, Chief Executive Officer of Canndeo Limited,

More information

No.Ayur-Ja (7)-1/97-III Dated, Shimla-2, the NOTIFICATION. In supersession of this Department s Office Order of even number

No.Ayur-Ja (7)-1/97-III Dated, Shimla-2, the NOTIFICATION. In supersession of this Department s Office Order of even number Government of Himachal Pradesh Department of Ayurveda No.Ayur-Ja (7)-1/97-III Dated, Shimla-2, the 31-8-2009 NOTIFICATION In supersession of this Department s Office Order of even number dated 5 th February,

More information

DELICA D:5 ACTIVE GEAR 0

DELICA D:5 ACTIVE GEAR 0 DELICA D:5 ACTIVE GEAR 0 1 1. FY2017 1Q Results 2. FY2017 1Q Results by Region 3. FY2017 Forecast 4. Initiatives for the Future FY2017 1Q Results Summary (vs. FY2016 1Q) (Apr-Jun 2016) (Apr-Jun 2017) (billion

More information

WntResearch. 100% one-week return? 16 October 2017 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE

WntResearch. 100% one-week return? 16 October 2017 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE Occasion: Initial coverage +37% +71% 100% one-week return? s share price has dropped by more than 50% since the announcement of the current and ongoing public offering. In theory the share price should

More information

RULES. on Selection and Sale of Tobacco and Trade Terms with Suppliers CHAPTER I

RULES. on Selection and Sale of Tobacco and Trade Terms with Suppliers CHAPTER I RULES on Selection and Sale of Tobacco and Trade Terms with Suppliers CHAPTER I Article 1 Purpose The purpose of these Rules is to define and explain the product choices of the State Alcohol and Tobacco

More information

HILLENBRAND INDUSTRIES INC

HILLENBRAND INDUSTRIES INC HILLENBRAND INDUSTRIES INC FORM 8-K (Unscheduled Material Events) Filed 2/17/2004 For Period Ending 2/13/2004 Address 700 STATE ROUTE 46 E BATESVILLE, Indiana 47006-8835 Telephone 812-934-7000 CIK 0000047518

More information

Altria Group Inc. Ticker: MO

Altria Group Inc. Ticker: MO Altria Group Inc. Ticker: MO Business Description Altria Group Inc. through its subsidiaries manufactures and sells cigarettes, other tobacco products, machine-made large cigars and pipe tobacco. It also

More information

Tandem Diabetes Care, Inc. (TNDM) - Medical Equipment - Deals and Alliances Profile

Tandem Diabetes Care, Inc. (TNDM) - Medical Equipment - Deals and Alliances Profile Tandem Diabetes Care, Inc. (TNDM) - Medical Equipment - Deals and Alliances Profile Tandem Diabetes Care, Inc. (TNDM) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business

More information

ŚCIŚLE POUFNE. The Company's presentation

ŚCIŚLE POUFNE. The Company's presentation The Company's presentation Warsaw, May 2017 Key figures #1 Leader of the market of reinforced concrete prefabricated elements in Poland 4 plants manufacturing reinforced concrete prefabricated elements

More information

Industry experience in consortium i.e. from BEE party or non-bee partners

Industry experience in consortium i.e. from BEE party or non-bee partners A. ENTREPRENEURSHIP FINANCE Imbewu Entrepreneurship Finance would provides risk capital to new businesses and to early stage businesses owned and managed by black people meeting the following criteria:

More information

Explanatory Memorandum to accompany the National Health Service (Dental Charges) (Wales) (Amendment) Regulations 2018

Explanatory Memorandum to accompany the National Health Service (Dental Charges) (Wales) (Amendment) Regulations 2018 Explanatory Memorandum to accompany the National Health Service (Dental Charges) (Wales) (Amendment) Regulations 2018 This Explanatory Memorandum has been prepared by the Primary Care Division of the Directorate

More information

Hong Leong Bank Berhad (97141 X) A Member of the Hong Leong Group. A Member of the Hong Leong Group ANNUAL REPORT 2008

Hong Leong Bank Berhad (97141 X) A Member of the Hong Leong Group. A Member of the Hong Leong Group ANNUAL REPORT 2008 Hong Leong Bank Berhad (97141 X) Hong Leong Bank Berhad (97141 X) A Member of the Hong Leong Group A Member of the Hong Leong Group ANNUAL REPORT 2008 Our Corporate Vision An Outstanding Financial Services

More information

Second Regular Session Seventieth General Assembly STATE OF COLORADO INTRODUCED

Second Regular Session Seventieth General Assembly STATE OF COLORADO INTRODUCED Second Regular Session Seventieth General Assembly STATE OF COLORADO INTRODUCED LLS NO. 1-0.01 Michael Dohr x HOUSE BILL 1-1 HOUSE SPONSORSHIP Pabon, Conti, Court, Foote, Garnett, Kagan, Priola, Roupe,

More information

Investor Presentation

Investor Presentation ASX:THC B u i l d i n g a M e d i c i n a l C a n n a b i s B u s i n e s s Investor Presentation November 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an

More information

QuickBooks Online Student Guide. Education Exercises Answer Key

QuickBooks Online Student Guide. Education Exercises Answer Key QuickBooks Online Student Guide Education Exercises Answer Key 2 Education Exercises Answer Key Chapter 1 Answer Key Exercise #1 You ll know that the student has been successful if you receive an email

More information

Invion Limited (ASX:IVX) Clinical-stage life sciences company targeting chronic inflammation

Invion Limited (ASX:IVX) Clinical-stage life sciences company targeting chronic inflammation Invion Limited (ASX:IVX) Clinical-stage life sciences company targeting chronic inflammation Investor Presentation March 2015 Overview 1. Revised strategy > To position company for near term strategic

More information

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS SPHERIX Investor Relations Phone: (301) 897-2564 Email: info@spherix.com SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS BETHESDA, MD, May 21, 2010 - Spherix Incorporated (NASDAQ CM: SPEX), an innovator

More information

HONG LEONG DEPOSIT & WIN CONTEST

HONG LEONG DEPOSIT & WIN CONTEST HONG LEONG DEPOSIT & WIN CONTEST Last updated on 7 July 2018 CONTEST PERIOD The Hong Leong Bank Berhad (97141-X) ( HLB ) and/or Hong Leong Islamic Bank Berhad (686191-W) ( HLISB ) [hereinafter collectively

More information

Results Presentation 2Q FY March Win-Partners Co., Ltd. (3183)

Results Presentation 2Q FY March Win-Partners Co., Ltd. (3183) Results Presentation 2Q FY March 2019 Win-Partners Co., Ltd. (3183) 2Q results ending September 2019 3 Consolidated results summary ( mil)2q to Sep 2017 Sep 2018 YoY OE Sales 29,753 31,863 +7.1% 31,700

More information

28 April 2017 ASX Code: COY. March 2017 Quarterly Activity Report

28 April 2017 ASX Code: COY. March 2017 Quarterly Activity Report 28 April 2017 ASX Code: COY The following report details the operating and corporate activities of Coppermoly Ltd (Coppermoly or the Company) for the quarter ended 31 March 2017 and to the date of this

More information

Non Performing Assets (NPAs): A Comparative Analysis of SBI and ICICI Bank

Non Performing Assets (NPAs): A Comparative Analysis of SBI and ICICI Bank Non Performing Assets (NPAs): A Comparative Analysis of SBI and ICICI Bank RAJESHWARI PARMAR Assistant Professor (Finance), Parul Institute of Business Administration, Limda. District: Vadodara Gujarat

More information

Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update Phase 3 Trial of Amphora for Hormone-free Contraception Continues to Move Ahead of Schedule; Top Line Data

More information

FY2009 First Quarter Financial Results. SUZUKI MOTOR CORPORATION August 3, 2009

FY2009 First Quarter Financial Results. SUZUKI MOTOR CORPORATION August 3, 2009 FY2009 First Quarter Financial Results SUZUKI MOTOR CORPORATION August 3, 2009 Consolidated: Financial Summary Page 2 FY2009 1Q FY2008 4Q 09/4-6 09/1-3 Change FY2008 1Q 08/4-6 Change (Billion Yen) (A)

More information

Enel Américas 1Q 2018 results

Enel Américas 1Q 2018 results Enel Américas 1Q 2018 results 1Q 2018 results Highlights of the period EBITDA of 820 musd, an increase of 26% vs 1Q 2017 Generation EBITDA increased by 17% due to better prices in Argentina and consolidation

More information

1Q 2009 Results Presentation. 12 May 2009

1Q 2009 Results Presentation. 12 May 2009 1Q 2009 Results Presentation 12 May 2009 1 Broadcasting 2 MEDIASET 2009 1Q Total Audience TOTAL AUDIENCE (Jan-Mar) * Individuals Δ vs. 2008 +5.3% 15-64 years +5.6% 1Q TV CONSUMPTION (2000-2009) Average

More information

Pink Bollworm Control Act

Pink Bollworm Control Act Pink Bollworm Control Act The Pink Bollworm Control Act provides for the establishment of pink bollworm control districts and committees, organic cotton regulations, collection of assessments and abolishment

More information